7-159030694-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003382.5(VIPR2):āc.1239C>Gā(p.Asn413Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000619 in 1,582,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00025 ( 0 hom., cov: 33)
Exomes š: 0.000042 ( 0 hom. )
Consequence
VIPR2
NM_003382.5 missense
NM_003382.5 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 0.559
Genes affected
VIPR2 (HGNC:12695): (vasoactive intestinal peptide receptor 2) This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.078680485).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VIPR2 | NM_003382.5 | c.1239C>G | p.Asn413Lys | missense_variant | 13/13 | ENST00000262178.7 | NP_003373.2 | |
VIPR2 | NM_001308259.1 | c.1191C>G | p.Asn397Lys | missense_variant | 10/10 | NP_001295188.1 | ||
VIPR2 | NM_001304522.2 | c.999C>G | p.Asn333Lys | missense_variant | 11/11 | NP_001291451.1 | ||
VIPR2 | NR_130758.2 | n.1669C>G | non_coding_transcript_exon_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VIPR2 | ENST00000262178.7 | c.1239C>G | p.Asn413Lys | missense_variant | 13/13 | 1 | NM_003382.5 | ENSP00000262178 | P2 | |
VIPR2 | ENST00000402066.5 | c.1662C>G | p.Asn554Lys | missense_variant | 13/13 | 5 | ENSP00000384497 | A2 | ||
VIPR2 | ENST00000377633.7 | c.1191C>G | p.Asn397Lys | missense_variant | 10/10 | 2 | ENSP00000366860 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152272Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
38
AN:
152272
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000707 AC: 14AN: 197904Hom.: 0 AF XY: 0.0000373 AC XY: 4AN XY: 107244
GnomAD3 exomes
AF:
AC:
14
AN:
197904
Hom.:
AF XY:
AC XY:
4
AN XY:
107244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000419 AC: 60AN: 1430562Hom.: 0 Cov.: 31 AF XY: 0.0000381 AC XY: 27AN XY: 708944
GnomAD4 exome
AF:
AC:
60
AN:
1430562
Hom.:
Cov.:
31
AF XY:
AC XY:
27
AN XY:
708944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000250 AC: 38AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74392
GnomAD4 genome
AF:
AC:
38
AN:
152272
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2023 | The c.1239C>G (p.N413K) alteration is located in exon 13 (coding exon 13) of the VIPR2 gene. This alteration results from a C to G substitution at nucleotide position 1239, causing the asparagine (N) at amino acid position 413 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Gain of MoRF binding (P = 0.0259);.;.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at